• Mc-Val-Cit-PABC-PNP: Practical Guide for ADC Peptide Linker

  2026-07-27

  Mc-Val-Cit-PABC-PNP addresses the challenge of controlled cytotoxic payload release in antibody-drug conjugate (ADC) research by providing a cathepsin B-cleavable peptide linker optimized for organic solvent-based workflows. It is not suitable for aqueous protocols, diagnostic, or therapeutic applications, ensuring precise use within targeted drug delivery research.

• Nutlin-3a: Potent MDM2 Inhibitor for p53 Pathway Activation

  2026-07-27

  Nutlin-3a is a benchmark MDM2 inhibitor that activates the p53 pathway and induces apoptosis in various cancer models. Its highly specific mechanism enables robust cell cycle arrest and precise study of p53-MDM2 interactions for cancer research.

• Netrin-1 Modulates Adipogenesis via PPARγ and Wnt/β-catenin

  2026-07-26

  This study reveals that adipose-derived Netrin-1 impedes healthy adipose tissue remodeling by inhibiting adipogenesis through PPARγ suppression and Wnt/β-catenin activation. The findings highlight Netrin-1 as a key regulator in high-fat-diet-induced obesity and a potential therapeutic target for metabolic disorders.

• METTL14–lncRNA Axis Regulates Inflammation in Ulcerative Col

  2026-07-25

  This study delineates how METTL14-mediated m6A RNA modification protects against colonic inflammation in ulcerative colitis through regulation of the lncRNA DHRS4-AS1/miR-206/A3AR axis. The findings provide mechanistic insight into posttranscriptional gene regulation in inflammatory bowel disease and suggest potential molecular targets for future therapeutic strategies.

• O6-Benzylguanine: Applied MGMT Inhibitor Protocols in Chemot

  2026-07-24

  O6-Benzylguanine streamlines advanced MGMT inhibition workflows, enabling researchers to efficiently sensitize cancer cells to alkylating agents and dissect DNA repair mechanisms. This guide delivers actionable, data-driven protocols and troubleshooting strategies, translating the latest mechanistic breakthroughs into robust experimental designs.

• Context-Dependent Senolytic Sensitivity in Melanoma Therapie

  2026-07-24

  This study defines how combination therapies induce distinct senescence phenotypes in human melanoma cells and identifies conditions under which Bcl-2/Bcl-xL inhibitors like Navitoclax are effective senolytics. The findings reveal that senolytic sensitivity is dictated by the nature of therapy-induced senescence, with direct implications for optimizing apoptosis assays and combination strategies in cancer biology research.

• PDX1 Mutation and m6A Methylation in Primate Pancreatic Agen

  2026-07-23

  Zhang et al. present the first CRISPR/Cas9-generated PDX1-mutant cynomolgus macaque model of MODY4, revealing a novel link between PDX1 haploinsufficiency, pancreatic agenesis, and altered m6A methylation. These findings clarify disease mechanisms previously inaccessible in rodent models and offer new targets for diabetes research.

• Verapamil HCl Targets Txnip to Modulate Osteoporosis Pathway

  2026-07-23

  This study reveals that verapamil, an established L-type calcium channel blocker, mitigates osteoporosis by targeting Txnip and modulating bone turnover in preclinical models. These findings provide mechanistic insight into verapamil’s actions on osteoclast and osteoblast signaling and highlight translational potential for managing postmenopausal osteoporosis.

• Protease Inhibitor Cocktail EDTA-Free: Optimizing Protein Ex

  2026-07-22

  Unlock high-fidelity protein analysis with the Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO), designed for maximal compatibility with phosphorylation and enzyme assays. This guide details hands-on workflows, troubleshooting, and novel insights from recent oocyte maturation research to elevate your proteomics results.

• Toremifene: Selective Estrogen-Receptor Modulator in Prostat

  2026-07-22

  Toremifene empowers researchers to dissect estrogen receptor signaling and calcium pathways in advanced prostate cancer models. This guide translates high-impact findings—like the TSPAN18–STIM1 axis—into actionable experimental workflows, protocol enhancements, and troubleshooting solutions for hormone-responsive cancer research.

• Benzyl-Activated Streptavidin Magnetic Beads: Optimizing Ear

  2026-07-21

  Explore how Benzyl-activated Streptavidin Magnetic Beads enable highly specific, efficient detection of early cell death and streamline advanced molecular assays. This article offers unique scientific insights into biotinylated molecule capture, bridging molecular mechanisms with practical protocol guidance.

• Neuroligin 1 Loss in Striatal D2 Neurons Drives Repetitive B

  2026-07-21

  This study establishes a direct mechanistic link between Neuroligin 1 deficiency in striatal D2 receptor-expressing medium spiny neurons and the emergence of autistic-like repetitive behaviors in mice. Single-nucleus transcriptomics reveal PKC overactivation as a molecular driver, providing actionable insight for targeted intervention studies.

• Adefovir (GS-0393): Mechanism-Driven Strategy for Translatio

  2026-07-20

  This article provides a comprehensive roadmap for translational researchers leveraging Adefovir (GS-0393) in hepatitis B virus (HBV) and renal transporter studies. By dissecting mechanistic, pharmacokinetic, and workflow evidence, we outline how to optimize assay design, interpret clinical relevance, and maximize reproducibility using APExBIO’s high-purity Adefovir. Drawing on recent population PK data and cross-domain guidance, we highlight best practices and emerging frontiers in antiviral drug discovery.

• Bufalin–CRISPR Nanomedicine Induces Pyroptosis in CRC Immuno

  2026-07-20

  A recent study developed a calcium lactate nanoparticle system co-delivering bufalin and CRISPR/Cas9 ribonucleoprotein to target colorectal cancer. This approach synergistically induces pyroptosis and apoptosis in tumor cells while reprogramming the immune microenvironment, offering a promising strategy for improving immunotherapy outcomes.

• Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301): P

  2026-07-19

  Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) provide targeted capture and rapid magnetic separation of biotinylated molecules from complex samples, addressing specificity and workflow efficiency in protein, nucleic acid, and cell-based assays. These beads are not suitable for applications requiring covalent capture of non-biotinylated targets or where ultra-high yield outweighs the need for minimized background.

16522 records 1/1102 page Next 12345 下5页 Last page